Cargando…

Inter‐laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples

BACKGROUND: Nitisinone is used to treat hereditary tyrosinemia type 1 (HT‐1) by preventing accumulation of toxic metabolites, including succinylacetone (SA). Accurate quantification of SA during newborn screening is essential, as is quantification of both SA and nitisinone for disease monitoring and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laeremans, Hilde, Turner, Charles, Andersson, Tommy, de Juan, Jose Angel Cocho, Gerrard, Adam, Heiner‐Fokkema, M. Rebecca, Herebian, Diran, Janzen, Nils, la Marca, Giancarlo, Rudebeck, Mattias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203657/ https://www.ncbi.nlm.nih.gov/pubmed/32395414 http://dx.doi.org/10.1002/jmd2.12112

Ejemplares similares

Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretion
por: Jack, Rhona M., et al.
Publicado: (2019)

Preventive use of nitisinone in alkaptonuria
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2021)

Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients
por: Genovese, Federica, et al.
Publicado: (2023)

Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
por: Imrich, Richard, et al.
Publicado: (2022)

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
por: Ranganath, L. R., et al.
Publicado: (2022)

Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1
por: Guffon, Nathalie, et al.
Publicado: (2017)

Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia
por: Céspedes, Nora, et al.
Publicado: (2017)

Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts
Publicado: (1985)

Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
por: Ranganath, Lakshminarayan R., et al.
Publicado: (2022)

Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day
por: Kienstra, Nienke S., et al.
Publicado: (2017)

Adequacy of nitisinone for the management of alkaptonuria
por: Abbas, Khawar, et al.
Publicado: (2022)

The Discovery of the Mode of Action of Nitisinone
por: Lock, Edward A.
Publicado: (2022)

Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
por: Ranganath, Lakshminarayan R., et al.
Publicado: (2022)

Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria
por: Ranganath, L.R., et al.
Publicado: (2022)

Differential Mechanism of ATP Production Occurs in Response to Succinylacetone in Colon Cancer Cells
por: Lee, Phil Jun, et al.
Publicado: (2019)

Mildly elevated succinylacetone and normal liver function in compound heterozygotes with pathogenic and pseudodeficient FAH alleles
por: Yang, Hao, et al.
Publicado: (2017)

Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy
por: Stinton, Chris, et al.
Publicado: (2017)

Electronic structure and molecular properties of nitisinone and mesotrione in water
por: Imrich, Richard, et al.
Publicado: (2023)

Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma
por: Blackburn, Patrick R., et al.
Publicado: (2016)

The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening
por: Priestley, Jessica R. C., et al.
Publicado: (2020)

Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(−/−)) mice
por: Tucci, Sara, et al.
Publicado: (2014)

A Stability Indicating HPLC Method for the Determination of Nitisinone in Capsules
por: Souri, Effat, et al.
Publicado: (2015)

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in Tyrosinemia
por: HONAR, Naser, et al.
Publicado: (2017)

Molecular docking analysis of nitisinone with homogentisate 1,2 dioxygenase
por: Zolfaghari, Narges
Publicado: (2017)

Repurposing the orphan drug nitisinone to control the transmission of African trypanosomiasis
por: Sterkel, Marcos, et al.
Publicado: (2021)

Dried blood spot versus venous blood sampling for phenylalanine and tyrosine
por: van Vliet, Kimber, et al.
Publicado: (2020)

Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria
por: Milan, A. M., et al.
Publicado: (2019)

Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
por: Couce, María Luz, et al.
Publicado: (2019)

Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
por: Ranganath, Lakshminarayan, et al.
Publicado: (2021)

Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
por: Davison, Andrew S., et al.
Publicado: (2022)

Tissue-Specific Strategies of the Very-Long Chain Acyl-CoA Dehydrogenase-Deficient (VLCAD(−/−)) Mouse to Compensate a Defective Fatty Acid β-Oxidation
por: Tucci, Sara, et al.
Publicado: (2012)

Stellate cells are mesenchymal stem cells
por: Kordes, Claus, et al.
Publicado: (2014)

Bile acids induce hepatic differentiation of mesenchymal stem cells
por: Sawitza, Iris, et al.
Publicado: (2015)

GSTZ1‐1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
por: Yang, Fan, et al.
Publicado: (2019)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria
por: Hughes, Juliette H., et al.
Publicado: (2020)

Metabolic profiles and fingerprints for the investigation of the influence of nitisinone on the metabolism of the yeast Saccharomyces cerevisiae
por: Barchanska, Hanna, et al.
Publicado: (2023)

Trace elements in dried blood spots as potential discriminating features for metabolic disorder diagnosis in newborns
por: Moreda-Piñeiro, Jorge, et al.
Publicado: (2021)

Functional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants
por: Sturm, Marga, et al.
Publicado: (2012)

Footprint-free human fetal foreskin derived iPSCs: A tool for modeling hepatogenesis associated gene regulatory networks
por: Matz, Peggy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pnq1no6830b5ghg6l2s6jukop0